BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 28140313)

  • 1. [Guidelines for molecular monitoring of BCR-ABL1 in chronic myeloid leukemia patients by RT-qPCR].
    Larripa I; Ruiz MS; Gutiérrez M; Bianchini M
    Medicina (B Aires); 2017; 77(1):61-72. PubMed ID: 28140313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment and validation of analytical reference panels for the standardization of quantitative BCR-ABL1 measurements on the international scale.
    White HE; Hedges J; Bendit I; Branford S; Colomer D; Hochhaus A; Hughes T; Kamel-Reid S; Kim DW; Modur V; Müller MC; Pagnano KB; Pane F; Radich J; Cross NC; Labourier E
    Clin Chem; 2013 Jun; 59(6):938-48. PubMed ID: 23471097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conversion, correction, and International Scale standardization: results From a Multicenter External Quality Assessment Study for BCR-ABL1 testing.
    Griffiths M; Patton SJ; Grossi A; Clark J; Paz MF; Labourier E;
    Arch Pathol Lab Med; 2015 Apr; 139(4):522-9. PubMed ID: 25061833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of droplet digital polymerase chain reaction for measuring BCR-ABL1 in chronic myeloid leukaemia in an international interlaboratory study.
    Scott S; Cartwright A; Francis S; Whitby L; Sanzone AP; Mulder A; Galimberti S; Dulucq S; Mauté C; Lauricella C; Salmon M; Rose S; Willoughby J; Boeckx N; Pallisgaard N; Maier J; Leibundgut EO; Zizkova H; Ling Goh L; Duong C; Tang WF; Ma E; Shivakumar Y; Beppu L; Bhagavatula P; Chantry A
    Br J Haematol; 2021 Jul; 194(1):53-60. PubMed ID: 34114218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a novel multiplex RT-qPCR assay for the quantification of leukemia-associated BCR-ABL1 translocation.
    Kottwitz D; El Hadi H; El Amrani M; Cabezas S; Dehbi H; Nadifi S; Quessar A; Colomer D; Moumen A; Sefrioui EL
    Int J Hematol; 2015 Sep; 102(3):335-41. PubMed ID: 26243622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of individual molecular response in chronic myeloid leukemia patients with atypical BCR-ABL1 fusion transcripts: recommendations by the EUTOS cooperative network.
    Schäfer V; White HE; Gerrard G; Möbius S; Saussele S; Franke GN; Mahon FX; Talmaci R; Colomer D; Soverini S; Machova Polakova K; Cross NCP; Hochhaus A; Ernst T
    J Cancer Res Clin Oncol; 2021 Oct; 147(10):3081-3089. PubMed ID: 33677711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of the challenge in measuring and standardizing BCR-ABL1.
    Yu S; Cui M; He X; Jing R; Wang H
    Clin Chem Lab Med; 2017 Aug; 55(10):1465-1473. PubMed ID: 28222016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BCR-ABL1 RT-qPCR for monitoring the molecular response to tyrosine kinase inhibitors in chronic myeloid leukemia.
    Press RD; Kamel-Reid S; Ang D
    J Mol Diagn; 2013 Sep; 15(5):565-76. PubMed ID: 23810242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular monitoring of chronic myeloid leukemia: international standardization of BCR-ABL1 quantitation.
    Zhen C; Wang YL
    J Mol Diagn; 2013 Sep; 15(5):556-64. PubMed ID: 23876601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RT-qPCR and RT-Digital PCR: A Comparison of Different Platforms for the Evaluation of Residual Disease in Chronic Myeloid Leukemia.
    Alikian M; Whale AS; Akiki S; Piechocki K; Torrado C; Myint T; Cowen S; Griffiths M; Reid AG; Apperley J; White H; Huggett JF; Foroni L
    Clin Chem; 2017 Feb; 63(2):525-531. PubMed ID: 27979961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of major BCR-ABL1 mRNA by digital polymerase chain reaction is useful for prediction of international scale.
    Furuya D; Moriai M; Koizumi Y; Endo T; Asanuma K; Yanagihara N; Takahashi S
    Int J Clin Oncol; 2019 Jul; 24(7):871-875. PubMed ID: 30798394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative BCR-ABL1 RQ-PCR fusion transcript monitoring in chronic myelogenous leukemia.
    Moore FR; Rempfer CB; Press RD
    Methods Mol Biol; 2013; 999():1-23. PubMed ID: 23666687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Programme for Harmonization to the International Scale in Latin America for BCR-ABL1 quantification in CML patients: findings and recommendations.
    Ruiz MS; Sánchez MB; Vera Contreras YM; Agrielo E; Alonso M; Altuna ME; Anchordoqui MS; Asinari M; Bonetto ME; Camargo M; Giere I; González J; Granda Alacote AC; Guerra J; Gutiérrez M; Maldonado C; Makiya R; Manrique G; Monaco ME; Rozo JC; Santamaría C; Seravalle A; Zea O; Zubillaga MN; Mordoh J; Larripa I; Bianchini M
    Clin Chem Lab Med; 2020 Nov; 58(12):2025-2035. PubMed ID: 32374276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular monitoring of chronic myeloid leukemia: principles and interlaboratory standardization.
    Cross NC; Hochhaus A; Müller MC
    Ann Hematol; 2015 Apr; 94 Suppl 2():S219-25. PubMed ID: 25814088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consensus on BCR-ABL1 reporting in chronic myeloid leukaemia in the UK.
    Cross NCP; White HE; Evans PAS; Hancock J; Copland M; Milojkovic D; Mason J; Craine S; Mead AJ
    Br J Haematol; 2018 Sep; 182(6):777-788. PubMed ID: 30125955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. International reporting scale of BCR-ABL1 fusion transcript in chronic myeloid leukemia: first report from India.
    Balasubramanian P; Chendamarai E; Markose P; Fletcher L; Branford S; George B; Mathews V; Chandy M; Srivastava A
    Acta Haematol; 2012; 127(3):135-42. PubMed ID: 22249155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guidelines for the measurement of BCR-ABL1 transcripts in chronic myeloid leukaemia.
    Foroni L; Wilson G; Gerrard G; Mason J; Grimwade D; White HE; de Castro DG; Austin S; Awan A; Burt E; Clench T; Farruggia J; Hancock J; Irvine AE; Kizilors A; Langabeer S; Milner BJ; Nickless G; Schuh A; Sproul A; Wang L; Wickham C; Cross NC
    Br J Haematol; 2011 Apr; 153(2):179-90. PubMed ID: 21382019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction for sustained deep molecular response of BCR-ABL1 levels in patients with chronic myeloid leukemia in chronic phase.
    Sasaki K; Kantarjian H; O'Brien S; Ravandi F; Konopleva M; Borthakur G; Garcia-Manero G; Wierda W; Daver N; Ferrajoli A; Takahashi K; Jain P; Rios MB; Pierce S; Jabbour E; Cortes JE
    Cancer; 2018 Mar; 124(6):1160-1168. PubMed ID: 29266206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a novel variant BCR-ABL1 fusion transcript in a patient with chronic myeloid leukemia: Implications for molecular monitoring.
    Crampe M; Haslam K; Kelly J; Conneally E; Langabeer SE
    Hematol Oncol Stem Cell Ther; 2017 Jun; 10(2):85-88. PubMed ID: 27013275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cartridge-based automated BCR-ABL1 mRNA quantification: solving the issues of standardization, at what cost?
    Cayuela JM; Macintyre E; Darlington M; Abdelali RB; Fund X; Villarese P; Tulliez M; Raffoux E; Sigaux F; Réa D; Seror V
    Haematologica; 2011 May; 96(5):664-71. PubMed ID: 21330326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.